Ranked #827 of 8,699 institutional investors
Kohlberg Kravis Roberts & Co. L.P.
New York, NY
$4.90B
US stock portfolio at live prices · today −$24.3M (−0.49%)
Live prices, last trade 10:58 AM ET
- Value at quarter end (Q3 2026)
- $4.72B
- Change from Q2 2026
- −$743.8M (−13.62%)
- Positions
- 11 · 0 new, 3 sold out
- Filed
- Nov 13, 2026
Not counted in the ranking: $319M of convertible notes and other principal-amount securities. $518M of holdings we could not match to a US listing are included at their reported quarter-end value.
Holdings
Q3 2026 13F, live pricesBTSG 34.8%HSIC 27.2%BBIO 13.0%CRGY 6.28%BV 3.67%
| Stock | Shares | Value, live | % of portfolio | vs Q2 2026 |
|---|---|---|---|---|
| BTSG BrightSpring Health Services, Inc. | 26,829,880 | $1.71B | 34.8% | Unchanged |
| HSIC Henry Schein, Inc. | 15,652,032 | $1.33B | 27.2% | Unchanged |
| BBIO BridgeBio Pharma, Inc. | 8,260,971 | $637M | 13.0% | Reduced −38% |
| CRGY Crescent Energy Company | 28,655,357 | $308M | 6.28% | Unchanged |
| BV BrightView Holdings, Inc. | 21,533,123 | $180M | 3.67% | Unchanged |
| GMRS GMR Solutions Inc. | 14,785,611 | $148M | 3.01% | Unchanged |
| KREF KKR Real Estate Finance Trust Inc. | 10,000,001 | $52.4M | 1.07% | Unchanged |
| FSK FS KKR Capital Corp. | 980,587 | $10.8M | 0.22% | Unchanged |
| TEM Tempus AI, Inc. | 127,090 | $7.1M | 0.14% | Added +8% |
| SPY State Street SPDR S&P 500 ETF Trust | 3,000 | $2.1M | <0.1% | Reduced −49% |
| CHRS Coherus Oncology, Inc. | 3,036,076 | $1.2M | <0.1% | Unchanged |